Press release
Peptide-Based Metabolic Disorder Therapeutics Market Is Forecasted To Increase At A Stellar CAGR Of 12% by 2033
Sedentary lifestyle adoption has catalyzed the incidence of metabolic disorders and also resulted in a high prevalence of health complications among individuals across the world. Growing digitization, poor eating habits, lack of physical activity, and increasing focus on health and fitness are other prospects that alter the demand outlook for metabolic disorder therapeutics and treatments on a global level. The aforementioned factors are also estimated to bolster demand for peptide-based cardiovascular therapeutics over the coming years.
๐๐ผ๐๐ป๐น๐ผ๐ฎ๐ฑ ๐ฎ ๐ฆ๐ฎ๐บ๐ฝ๐น๐ฒ ๐๐ผ๐ฝ๐ ๐ผ๐ณ ๐ง๐ต๐ถ๐ ๐ฅ๐ฒ๐ฝ๐ผ๐ฟ๐:https://www.factmr.com/connectus/sample?flag=S&rep_id=187?PJ
Due to tight regulation and high outsourcing costs, key companies are engaged in the in-house development of peptide therapeutics. Large pharmaceutical companies prefer to manufacture in-house because they have the right infrastructure for large-scale manufacture.
Cancer has emerged as the second-leading chronic disease in the peptide-based metabolic disorders therapeutics market. The key factors driving the progress of this segment are the rising global cancer cases and increasing prescriptions of peptide therapeutics for the treatment of cancer. Increasing demand for effective and fast-acting therapeutics is anticipated to spur development of this market in the coming years.
Escalating awareness among healthcare workers and patients of the side effects of radiation and chemotherapy therapy is also a key factor. The presence of a robust product pipeline is also projected to assure market expansion. Fact.MR's research suggests that peptides are gaining momentum in the United States healthcare business and will undergo clinical trials.
๐๐ฒ๐ ๐ง๐ฎ๐ธ๐ฒ๐ฎ๐๐ฎ๐๐:
Based on the distribution channel, the online pharmacies segment acceleration rate is estimated to be around 11% CAGR from 2023 to 2033.
North America peptide-based metabolic disorder therapeutics market is likely to rise at a CAGR of 10.6% between 2023 and 2033.
India, Korea, and Japan are expected to be prominent markets as government initiatives supportive of market expansion surge.
The United States peptide-based metabolic disorder therapeutics market is anticipated to develop at a robust pace in the coming years.
China is expected to emerge as the most lucrative market for peptide-based metabolic disorder therapeutics over the next decade.
๐๐ฟ๐ผ๐๐๐ต ๐๐ฟ๐ถ๐๐ฒ๐ฟ๐:
A surge in the number of chronic diseases such as cancer and the use of peptides for treatment is driving the peptide-based metabolic disorders therapeutics market.
The rising use of peptides in cosmeceutical operations to slow down the process of skin aging is further accelerating the market.
Increasing investments in research & development for exploring new applications for peptide-based metabolic disorders therapeutics are anticipated to play a key role in market development.
๐ฅ๐ฒ๐๐๐ฟ๐ฎ๐ถ๐ป๐๐:
Supply chain management and safety regulation issues by regulatory bodies are on course to emerge as key challenges for market players.
๐๐ผ๐บ๐ฝ๐ฒ๐๐ถ๐๐ถ๐๐ฒ ๐๐ฎ๐ป๐ฑ๐๐ฐ๐ฎ๐ฝ๐ฒ:
The market is anticipated to be dominated by Eli Lilly Company, Ipsen S.A, PolyPeptide Group, Bachem Holding AG., CordenPharma International, PolyPeptide Group, and Novo Nordisk A/S, according to Fact. MR.
New product launches, investments in research & development activities, mergers, joint ventures, acquisitions, facility expansions, and partnerships are the key tactics employed by leading companies. Players are also exploring new production technologies and techniques to reduce costs and save time.
Recent Developments:
In January 2022, Amgen and Generate Biomedicines entered into a research partnership to discover and improve protein therapeutics across several therapeutic areas and establish delivery routes for clinical targets.
In February 2022, Amgen and Plexium, Inc. announced a multi-year research collaboration and licensing agreement to develop new targeted proteolytic therapeutics against previously tough drug targets. A multi-year partnership will support the development of new molecular adhesive therapeutics by leveraging Amgen's expertise in emerging multispecific molecules.
๐ง๐ผ๐ฝ ๐๐ผ๐บ๐ฝ๐ฎ๐ป๐ถ๐ฒ๐ ๐ฃ๐ฟ๐ผ๐ณ๐ถ๐น๐ฒ๐ฑ
Eli Lilly Company
Ipsen S.A
PolyPeptide Group
Bachem Holding AG.
CordenPharma International
PolyPeptide Group
Novo Nordisk A/S
Merck & Co. Inc
Teva Pharmaceutical Industries Ltd.
AstraZeneca PLC
๐ ๐ผ๐ฟ๐ฒ ๐ฉ๐ฎ๐น๐๐ฎ๐ฏ๐น๐ฒ ๐๐ป๐๐ถ๐ด๐ต๐๐ ๐ผ๐ป ๐๐ต๐ฒ ๐ ๐ฎ๐ฟ๐ธ๐ฒ๐
In its research, Fact.MR reveals key factors anticipated to lift the development of the global peptide-based metabolic disorders therapeutics market over the forecast period (2023 to 2033). The study also offers an in-depth analysis of the opportunities and drivers expected to boost sales of peptide-based metabolic disorders therapeutics through detailed segmentation as follows:
๐๐ ๐๐ฟ๐๐ด:
Liraglutide
Exenatide
Others
๐๐ ๐๐ถ๐๐๐ฟ๐ถ๐ฏ๐๐๐ถ๐ผ๐ป ๐๐ต๐ฎ๐ป๐ป๐ฒ๐น:
Hospital
Retail
Online
๐๐ ๐ฅ๐ฒ๐ด๐ถ๐ผ๐ป:
North America
Latin America
Europe
Asia Pacific
The Middle East and Africa
๐๐ฒ๐ ๐ค๐๐ฒ๐๐๐ถ๐ผ๐ป๐ ๐๐ผ๐๐ฒ๐ฟ๐ฒ๐ฑ ๐ถ๐ป ๐๐ต๐ฒ ๐ฅ๐ฒ๐ฝ๐ผ๐ฟ๐
What will be the demand outlook for the peptide-based metabolic disorders therapeutics market from 2023 to 2033?
Which are the challenges faced in the peptide-based metabolic disorders therapeutics market?
Which region will lead the growth in the global peptide-based metabolic disorders therapeutics market between 2023 and 2033?
What is the projected market valuation of the peptide-based metabolic disorders therapeutics market in 2033?
Which are the factors driving the peptide-based metabolic disorders therapeutics market from 2023 to 2033?
Which region will generate the maximum revenue in the global peptide-based metabolic disorders therapeutics market?
๐๐ฒ๐ ๐๐๐๐๐ผ๐บ๐ถ๐๐ฎ๐๐ถ๐ผ๐ป ๐ผ๐ป ๐๐ต๐ถ๐ ๐ฅ๐ฒ๐ฝ๐ผ๐ฟ๐ ๐ณ๐ผ๐ฟ ๐ฆ๐ฝ๐ฒ๐ฐ๐ถ๐ณ๐ถ๐ฐ ๐ฅ๐ฒ๐๐ฒ๐ฎ๐ฟ๐ฐ๐ต ๐ฆ๐ผ๐น๐๐๐ถ๐ผ๐ป๐:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=187?PJ
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E Mail : sales@factmr.com
Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range - from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Peptide-Based Metabolic Disorder Therapeutics Market Is Forecasted To Increase At A Stellar CAGR Of 12% by 2033 here
News-ID: 3262515 • Views: โฆ
More Releases from Fact.MR
Trauma Devices Market is Estimated to Reach USD 29.1 Billion by 2035 | DePuy Syn โฆ
Fact.MR today released its latest report on the Trauma Devices Market, providing comprehensive insights into the global market's robust growth driven by rising traumatic injuries, advancements in medical technologies, and increasing global awareness of trauma care. Valued at USD 12.9 billion in 2025, the market is projected to expand at a compound annual growth rate (CAGR) of 8.7%, reaching USD 29.1 billion by 2035.
For More Insights into the Market,โฆ
Microbiome Therapeutics Market is Projected to Reach USD 3,121.8 Million by 2035 โฆ
The global microbiome therapeutics market is valued at USD 823.5 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 14.2%, reaching USD 3,121.8 million by 2035. This robust expansion is driven by the increasing recognition of the human microbiome's role in managing chronic diseases, combined with rising investments in precision medicine and biotechnology innovation. As research uncovers the microbiome's influence on health conditionsโฆ
Insulin Patch Pumps Market is Anticipated to Reach USD 4.29 Billion by 2035
The global insulin patch pumps market is poised for substantial growth, with its valuation expected to rise from USD 1.42 billion in 2025 to USD 4.29 billion by 2035, reflecting a robust compound annual growth rate (CAGR) of 11.7%. This expansion is primarily driven by the escalating prevalence of diabetes worldwide and the increasing demand for convenient, discreet insulin delivery devices. As patients seek wearable insulin management systems that offerโฆ
Wearable Payment Devices Market is Expanding USD 133.09 Billion by 2034 | Fact.M โฆ
The global wearable payment devices market is valued at USD 33.47 billion in 2024 and is projected to expand to USD 133.09 billion by 2034, growing at a compound annual growth rate (CAGR) of 14.8%. This impressive growth is driven by the increasing adoption of contactless payment technologies, advancements in wearable devices, and rising consumer preference for convenient, secure transaction methods.
For More Insights into the Market, Request a Sampleโฆ
More Releases for Based
Electromagnetic Weapons Market : Land-Based, Air-Based, and Sea-Based 2021-2030
The global electromagnetic weapons market was valued at $350.0 million in 2020, and is projected to reach $2,060.1 million by 2030, registering a CAGR of 19.7% from 2021 to 2030.
Access Free sample PDF Copy of the Report - https://www.alliedmarketresearch.com/request-sample/15793
On the basis of platform, the electromagnetic weapons market is segregated into land-based, air-based, and sea-based. In 2020, the sea-based segment dominated the market. Developed nations such as the U.S. have startedโฆ
Battery Management System Market : Lithium-Ion Based, Lead-Acid Based, Nickel-Ba โฆ
The global battery management system market generated $5.81 billion in 2019, and is estimated to reach $24.83 billion by 2027, registering a CAGR of 20.2% from 2020 to 2027 by Battery Type (Lithium-Ion Based, Lead-Acid Based, Nickel-Based, and Others), Topology (Centralized, Distributed, and Modular), and Application (Automotive, Telecommunication, Consumer Electronics, Industrial, and Others): Global Opportunity Analysis and Industry Forecast, 2020-2027
Download Report Sample : https://www.alliedmarketresearch.com/request-sample/7002
COVID-19 Scenario :
The manufacturers have stopped theโฆ
Higher Education Game-based Learning Market By Type (Rognitive Ability-Based Gam โฆ
On a global scale, the Higher Education Game-based Learning market is currently showing significant development. The innovative methods and market study have helped many of the major players McGraw-Hill Education, PlayGen, Toolwire, Totem Learning, Lumos Labs, Triseum, Designing Digitally, Forio, Innovative Dutch, LearningWare to carve a name for themselves in the competitive global market. The Higher Education Game-based Learning market is experiencing a massive growth velocity due to the newโฆ
Hardware Security Modules Market by Type LAN Based, PCIE Based, USB Based
Hardware Security Modules Market is expected to witness high growth during the forecast period.The hardware security modules market was valued at USD 520.3 Million in 2016 and is expected to reach USD 1,101.2 Million by 2022, at a CAGR of 12.87% during the forecast period. The base year considered for the study is 2016, and the forecast for the market size is provided for the period between 2017 and 2022.
Factorsโฆ
Meat Substitute Market by Product Type (Tofu-based, Tempeh-based, TVP-based, Sei โฆ
The global meat substitute market size was valued at $7.5 billion by 2025, registering a CAGR of 7.7% during the forecast period (2018-2025). Meat is an excellent source of protein but contains high level of cholesterol and saturated fats. Individuals who consume it on a regular basis are more prone to develop health problems such as obesity and atherosclerosis.
Get Sample@ https://www.researchbeam.com/meat-substitute-market/request-sample
Meat substitutes are products that resemble actual meat inโฆ
Green & Bio-based Solvents Market Analysis, Demand, & Opportunities till 2023 | โฆ
A latest research report titled as โGreen & Bio-based Solvents Market for Paints & Coatings, Printing Inks, Commercial & Domestic Cleaning, Adhesives & Sealants, Pharmaceutical, Cosmetics, and Other Applications - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023โ has been recently added to the vast portfolio of Market Research Reports Search Engine (MRRSE) online research offerings. This report is a professional and in-depth analysis on theโฆ
